Medscape CME

The following authors have disclosed no relevant financial relationships:

• Massimo Imazio, MD
• Antonino Maria Cotroneo, MD
• Gianni Gaschino, MD
• Alessandra Chinaglia, MD
• Pietro Gareri, MD
• Roberto Lacava, MD
• Tommaso Diego Voci, MD
• Rita Trinchero, MD

Charles P. Vega, MD
Disclosure: Charles P. Vega, MD, has disclosed that he has served as an advisor or consultant to Novartis, Inc.

Graham Jackson, MD, FESC, FRCP, FACC
Disclosure: Graham Jackson, MD, FESC, FRCP, FACC, has disclosed that he is an academic advisor to Pfizer, Lilly, Plethora, Shire, and Servier. Dr. Jackson is also the chairman of the Sexual Dysfunction Association.

Leslie Citrome, MD, MPH
Disclosure: Leslie Citrome, MD, MPH, has disclosed that he is consultant for, has received honoraria from, or has conducted clinical research supported by Abbott, AstraZeneca, Avanir, Azur, Barr, Bristol-Myers Squibb, Eli Lilly, Forest Research Institute, GlaxoSmithKline, Janssen, Jazz, Pfizer, and Vanda.

Karen Costenbader, MD, MPH
Disclosure: Karen Costenbader, MD, MPH, has disclosed no relevant financial relationships.

Serge Jabbour, MD
Disclosure: Serge Jabbour, MD, has disclosed that he is on the speaker's bureau for Amylin and Eli Lilly.

Rubin Minhas, MB, ChB
Disclosure: Rubin Minhas, MB, ChB, has disclosed no relevant financial relationships.

Matt Rosenberg, MD, BA
Disclosure: Matt Rosenberg, MD, BA, has disclosed that he is a consultant for or has received fees for non-CME services from Abbott, Allergan, Astellas, Esprit Pharma, GlaxoSmithKline, Novartis, Ortho-McNeil, Pfizer, Roche, sanofi-aventis, and Verathon. Dr. Rosenberg has conducted research funded by sanofi-aventis.

Jagdish Sharma, FRCP
Disclosure: Jagdish Sharma, FRCP, has disclosed no relevant financial relationships.

Anthony Wierzbicki, FACA, FACB
Disclosure: Anthony Wierzbicki, FACA, FACB, has disclosed that he has received support for travel or lecture honoraria from Abbott, AstraZeneca, Bristol-Myers Squibb, Genzyme, Gilead, Merck KGaA, Merck, Sharp & Dohme, Pfizer, Roche, Schering-Plough, and Solvay Fournier. Dr. Wierzbicki is an advisory board member for Abbott, AstraZeneca, Bristol-Myers Squibb, Genzyme, Gilead, Kowa, LifeCyclePharma, Merck KGaA, Merck, Sharp & Dohme, Pfizer, Roche, Schering-Plough, Solvay Fournier, Surface Logix, and Takeda.

Carol Peckham
Disclosure: Carol Peckham has disclosed no relevant financial relationships.